| Literature DB >> 16804845 |
A C Linhares1, Thomas Verstraeten, Judith Wolleswinkel-van den Bosch, Ralf Clemens, Thomas Breuer.
Abstract
The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16804845 DOI: 10.1086/505493
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079